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Figure 2. Age-adjusted survival curves for sarcopenia 




Mean age was 78.5 (± 3.5) years. After 15 years of follow-up, 
180 men (87%) died. Median survival time was 8.4 (4.9 – 
13.3) years. 
THE FOUNDATION FOR THE NATIONAL INSTITUTES  
OF HEALTH (FNIH) - CRITERIA FOR SARCOPENIA  
PREDICT 15-YEAR MORTALITY IN AMBULATORY OLDER MEN 
The Foundation for the National Institutes of Health (FNIH) 
Sarcopenia Project recently developed new criteria for 
diagnosis of weakness and low muscle mass in older adults, 
which were associated with increased likelihood for incident 
mobility impairment . However, mortality risk patterns were 
inconsistent and further validation of their criteria for low 
grip strength and low appendicular lean mass (ALM)-to-
body mass index (BMI) ratio in other populations is needed 
(McLean et al., 2014 Journals of Gerontology). 
In this study, we aimed to evaluate the FNIH cut-off points 
for weakness and low muscle mass for prediction of all-
cause mortality in a sample of apparently healthy 
community-dwelling older men in Belgium with long-term 
follow-up. 
 Community-based, observational, cohort study in ambulatory men 
aged 70 and more at baseline in 1996. 
 Presence of the FNIH criteria for sarcopenia was identified in 200 men 
based on data acquired at the fifth visit in 2000.  
 Weakness (Jamar type dynamometry) was defined as low grip strength 
(< 26 kg) or low grip strength-to-body mass index (BMI) ratio (< 1.00).  
 Low muscle mass (dual-energy x-ray absorptiometry) was categorized 
as low appendicular lean mass (ALM; predefined < 19.75 kg) or low 
ALM-to-BMI ratio (predefined < 0.789).  
 Data on all-cause mortality were obtained through yearly postal 
questionnaires and by contacting proxies and the treating general 
practitioners via telephone. Survival time was calculated as the number 
of months from assessment in 2000 until death or up to 15 years of 
follow-up.  
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Our findings confirm the predictive value for mortality of the FNIH criteria for weakness and low muscle mass in older community-
dwelling Belgian men. The non-distribution based character of these criteria facilitates their application in clinical setting.  
Figure 1. Association of sarcopenia states with all-cause mortality after 15 
years of follow-up in community-dwelling older Belgian men (N = 200). 
 
 
